They support us
They support us
BPI, France Relance et France 2030
The SEM EDIT-B project aims to validate the clinical utility of the EDIT-B test for unipolar and bipolar depressed patients and perform a health economics study for EDIT-B. This project was financed by the French Government as part of France 2030 and by the European Union – Next Generation EU as part of the France Relance plan.
The EDIT-B Consortium and project aim to solve the bipolar disorder diagnostic challenge by using specific RNA editing based biomarkers and artificial intelligence to validate and commercialize a high performance and quick blood test to diagnose bipolar disorder.
NeuroDeRisk is an “Innovative Medicines Initiative” (IMI2) project aiming to provide novel validated integrated tools for improving the preclinical prediction of adverse effects of pharmaceuticals on the nervous system and thus help to de-risk drug candidates earlier in the Research and Development phases.
ALCEDIAG has a recurring partnership with Sys2Diag, a laboratory from the CNRS (French National Center for Scientific Research). Sys2Diag runs cutting edge research for innovation in medical diagnosis and next generation medical interactives devices engineering.
ALCEDIAG is engaged into a recurring partnership with GHU Paris Psychiatrie & Neurosciences, the leading hospital player in mental illnesses and the nervous system in France.
ALCEDIAG is a member of Alliance Fondamental, a think tank aiming to boost research in mental health, facilitate knowledge sharing between all stakeholders (clinicians, researchers, industrials, etc.).
ALCEDIAG is a partner of and works with Bipolarite France, a patient association focusing on bipolar disorder and putting patients at the center of their action as “actors of their pathologies and authors of their lives”
ALCEDIAG is a member of France Biotech, the French trade association of biotechnology companies.
ALCEDIAG is a member of Medicen the Île-de-France / Paris competitiveness cluster focusing on health, gathering more than 510 innovators in health.